A wearable device claiming to block the pain of opioid withdrawal has been cleared by the Food and Drug Administration under an expedited review process for medical devices. However, patient safety advocates note that the device has limited evidence for its effectiveness

Quick Read

Jon McHann, 56, got started on prescription opioids the way a lot of adults in the U.S. did: he was in pain following an accident. In his case, it was a fall. “I hit my tailbone just right, and created a severe bulging disc” that required surgery, McHann says. McHann, who lives in Smithville, Tenn., expected to make a full recovery and go back to work as a heavy haul truck driver. But 10 years after his accident, he’s still at home

Quick Read

Another lawmaker is asking insurers whether their policies have made it easier for patients to access cheaper, more addictive drugs over less addictive alternatives. Meanwhile, the insurance industry trade group pledged additional steps to combat inappropriate prescribing

Quick Read

It’s worth noting that Medicaid expansion helps pay for opioid addiction treatment, said Brendan Saloner of Johns Hopkins Bloomberg School of Public Health. Medicaid expansion covers costs treatments like detoxification, outpatient treatment, and treatment for masked health conditions

Quick Read

Concern over illicit use and addiction is putting morphine out of reach for millions of patients globally who need it for pain relief

Quick Read

With the country in the throes of an epidemic, communities across the nation are being forced to confront the harrowing, and often fatal, effects of opioid abuse. But solutions — such as creating intervention programs in Ohio, providing access to treatment in Alabama, or investing in prevention initiatives in Missouri — cost money

Quick Read

An Ethical Dilemma for Doctors

September 25, 2017

When is it OK to prescribe opioids? Our Travis Rieder writes, “America’s opioid crisis is getting worse. The role of prescription opioids has both the medical establishment and the government justifiably worried.”

Read More

First, Do No Harm

September 21, 2017

Marshaling Clinician Leadership to Counter the Opioid Epidemic | A Special Publication from the National Academy of Medicine

Read More